Here’s Why I Might Change My Mind and Buy WELL Stock

Here’s why I think WELL Health (TSX:WELL) could be an intriguing proposition for some long-term investors right now.

| More on:

In the rapidly evolving healthcare industry, WELL Health Technologies (TSX: WELL) is one of the prominent Telehealth companies in Canada and the United States. WELL offers digital healthcare innovations that make healthcare accessible, more efficient, and with quality service provision through technology.

Although I have been quite conservative when discussing WELL stock in the past, here are a few reasons why investors may want to consider this company.

doctor uses telehealth

Source: Getty Images

It’s all about growth

In the telehealth space, investors may not be surprised to hear that growth is abundant. Patients are looking for innovative solutions to being seen by their doctors, and with wait times and patient access metrics deteriorating in past decades, one could argue that the sort of services WELL provides can make the world a better place.

It does appear the overall marketplace thinks so. The company’s strong revenue growth in past quarters is a combination of organic growth within its existing groups, as well as a robust acquisition strategy. WELL has undertaken a strategic mission of acquiring a range of high-quality digital health and telemedicine assets. Some notable companies that fit into the category include CRH Medical, MyHealth Partners, and WISP entities that expand WELL’s capabilities across a gamut of healthcare services.

These acquisitions have bolstered the company’s financials, with double-digit revenue growth seen across its business lines in recent quarters. Much of this growth has indeed come via its acquisitions, so as long as the company can continue to pay the right price for these deals, this is a stock I think could be worth considering here.

Recurring revenue model is worth looking at

Revenue growth is one thing, but how that revenue comes in also matters. In the case of WELL Health, the company’s recurring revenue streams provide investors with added stability. These stable subscription-based revenues, particularly seen in the company’s EMR services and telehealth platforms, improve the company’s cash flow predictability, creating a robust base for long-term growth when the company scales up its operation.

With stable recurring revenue, WELL is in a better position to face market fluctuations and can focus its attention on reinvesting in its growth strategy. Furthermore, the firm’s ability to generate solid cash flows indicates to the outside world its potential to maintain and enhance its operations. 

Long-term potential of the telemedicine sector

Telemedicine is a long-term shift rather than a trend stirred up by the pandemic. WELL Health’s virtual care solutions include phone and video consultations, remote monitoring, and digital referrals. In addition, all these are in an excellent position to capture the long-term growth of the telemedicine industry.

Moreover, the telemedicine market is poised to grow significantly soon with improved demand for remote healthcare options and persistent advancements in digital health technologies. WELL’s expansion in its penetration of the massive U.S. market through acquisitions, such as CRH Medical, further strengthens its digital healthcare solution offerings. 

With the steadily growing dependency on these services from patients and providers, WELL’s telemedicine operations will generate recurring revenues that will eventually lead to the company’s profitability.

WELL’s well-rounded platform offers a holistic suite of services beyond basic telemedicine. From digital solutions improving clinical workflows and patient engagement, WELL has delivered just as much value as it adds to healthcare providers. In addition, it is also just as much as it is strengthening its competitive advantage in the healthcare industry.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

runner checks her biodata on smartwatch
Stocks for Beginners

Gildan’s Vertically Integrated Supply Chain Could Be the Best Tariff Shield Yet

Gildan’s vertically integrated supply chain and trade-friendly manufacturing footprint could help it protect margins as tariffs shift.

Read more »

Young Boy with Jet Pack Dreams of Flying
Stocks for Beginners

This Canadian Stock Could Be the Hidden Gem of the Decade

This hidden Canadian gem combines strong revenue growth, a $4 billion backlog, and expanding satellite capabilities.

Read more »

pregnant mother juggles work and childcare
Dividend Stocks

Furniture Just Got a Lot More Expensive in Canada: Is Leon’s Stock a Winner or a Loser?

Leon's Furniture's roughly 3.9% dividend yield and discount to the analyst consensus price target could make it an attractive recovery…

Read more »

alcohol
Dividend Stocks

This Stock Could Be a Retirement Game-Changer

This Canadian retirement stock combines strong recent gains, growing financial businesses, and reliable quarterly dividends.

Read more »

man touches brain to show a good idea
Dividend Stocks

Exporters (Including Canadian National Railway) Face New Tariff Risk This Week: What Investors Need to Know

Canadian National Railway faces fresh tariff-related uncertainty as Canada-U.S. trade tensions escalate, but its strong earnings, cash flow, and growth…

Read more »

u.s. government spending
Dividend Stocks

U.S.-Canada Trade Talks Have Collapsed: Should You Sell Your Exporter Stocks?

U.S.-Canada trade tensions are heating up, but investors may want to look beyond the tariff noise before dumping these two…

Read more »

stock chart
Tech Stocks

This Stock Is Down 35% From its High: The Business Looks Better Than the Price

Constellation Software is down about 35%, but revenue and cash flow are still growing, making the drop worth a closer…

Read more »

crisis concept, falling stairs
Dividend Stocks

Down 13% From its All-Time High: Is This High-Yield Dividend Stock a Buy Right Now?

This top energy infrastructure player has attractive growth potential, but faces some near-term headwinds.

Read more »